^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CHS-114

    i
    Associations
    News

    Trials

    Company:
    Coherus Biosci
    Drug class:
    CCR8 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of CHS-114 in Participants With Advanced Solid Tumors (SRF114-101) (NCT05635643)
    Phase 1
    Coherus Biosciences, Inc.
    Recruiting
    Last update posted :
    02/05/2025
    Initiation :
    12/15/2022
    Primary completion :
    02/01/2026
    Completion :
    02/01/2026
    PD-L1
    |
    CHS-114